Patents by Inventor Ali Ait Ikhlef

Ali Ait Ikhlef has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOLECULAR TARGET OF NEUROTOXICITY
    Publication number: 20120202846
    Abstract: The present invention relates to the fields of biology, genetics and medicine. In particular it concerns new methods for the detection, characterisation and/or treatment (or management) of neurodegenerative diseases, particularly amyotrophic lateral sclerosis. The invention equally concerns methods for identifying or screening compounds active in these diseases. The invention further concerns the compounds, genes, cells, plasmids or compositions useful for implementing the hereinabove methods. In particular, the invention describes the role of PDE4B in these diseases and its use as a therapeutic, diagnostic or experimental target.
    Type: Application
    Filed: March 28, 2012
    Publication date: August 9, 2012
    Applicant: Exonhit Therapeutics SA
    Inventors: Ali AIT IKHLEF, Annelies Resink, Fabien Schweighoffer
  • MOLECULAR TARGET OF NEUROTOXICITY
    Publication number: 20100204251
    Abstract: The present invention relates to the fields of biology, genetics and medicine. In particular it concerns new methods for the detection, characterisation and/or treatment (or management) of neurodegenerative diseases, particularly amyotrophic lateral sclerosis. The invention equally concerns methods for identifying or screening compounds active in these diseases. The invention further concerns the compounds, genes, cells, plasmids or compositions useful for implementing the hereinabove methods. In particular, the invention describes the role of PDE4B in these diseases and its use as a therapeutic, diagnostic or experimental target.
    Type: Application
    Filed: December 1, 2009
    Publication date: August 12, 2010
    Applicant: EXONHIT THERAPEUTICS SA
    Inventors: Ali AIT IKHLEF, Annelies Resink, Fabien Schweighoffer
  • Molecular target of neurotoxicity
    Patent number: 6855736
    Abstract: The present invention relates to the fields of biology, genetics and medicine. In particular it concerns new methods for the detection, characterization and/or treatment (or management) of neuro degenerative diseases, particularly amyotrophic lateral sclerosis.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: February 15, 2005
    Assignee: Exonhit Therapeutics SA
    Inventors: Ali Ait Ikhlef, Annelies Resink, Fabien Schweighoffer
  • Novel molecular target for neurotoxicity
    Publication number: 20040219552
    Abstract: The present invention relates to the fields of biology, genetics and medicine. In particular it concerns new methods for the detection, characterisation and/or treatment (or management) of neurodegenerative diseases, particularly amyotrophic lateral sclerosis. The invention equally concerns methods for identifying or screening compounds active in these diseases. The invention further concerns the compounds, genes, cells, plasmids or compositions useful for implementing the hereinabove methods. In particular, the invention describes the role of PDE4B in these diseases and its use as a therapeutic, diagnostic or experimental target.
    Type: Application
    Filed: February 12, 2004
    Publication date: November 4, 2004
    Inventors: Ali Ait Ikhlef, Annelies Resink, Fabien Schweighoffer
  • Molecular target of neurotoxicity
    Publication number: 20030064374
    Abstract: The present invention relates to the fields of biology, genetics and medicine. In particular it concerns new methods for the detection, characterization and/or treatment (or management) of neuro degenerative diseases, particularly amyotrophic lateral sclerosis.
    Type: Application
    Filed: October 25, 2001
    Publication date: April 3, 2003
    Inventors: Ali Ait Ikhlef, Annelies Resink, Fabien Schweighoffer